Here's a look at some of the top regulatory stories for medical device companies this week: Report: Medtronic shareholder sues to block Covidien merger; Medtronic pays up to $105 million for Visualase; Elekta eyes Turkish radiology market with acquisition of Mesi Medikal; Ulthera pulls $86M IPO in favor of $600M merger
Healthcare-provider alliance SharedClarity signs some of medtech's biggest firms to land specialized pricing for peripheral stents.
Four of medtech's biggest firms agreed to offer peripheral stents at specialized prices to members of SharedClarity, an organization formed through the alliance of some of the country's largest health insurance and care providers.
Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger
Charles Dockendorff, the outgoing CFO at Covidien, is named to the board of directors at Haemonetics.
, BSD Medical
, Invacare Corp.
, Life Sciences Foundation
, Oncologix Tech Inc.
, Philips Healthcare
, Reva Medical Inc.
Covidien's fiscal 3rd-quarter sales come in dead even with expectations on Wall Street as its earnings top analysts' consensus estimate.
A Medtronic shareholder is reportedly looking to block the pending, $43 billion merger with Covidien, arguing that the deal leaves stockowners on the hook for significant tax liabilities.
Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Allergan cuts 1,500 jobs, faces SEC complaint; A countdown to failure for Valeant's hostile $53B Allergan takeover; GE Healthcare idles for another quarter